Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment.

G Luef; M Rauchenzauner; M Waldmann; W Sturm; A Sandhofer; K Seppi; Eugen Trinka; I Unterberger; C F Ebenbichler; M Joannidis; G Walser; G Bauer; F Hoppichler; M Lechleitner

doi:10.1016/j.eplepsyres.2009.04.004

Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment.

G Luef, M Rauchenzauner, M Waldmann, W Sturm, A Sandhofer, K Seppi, Eugen Trinka (Co-Autor/-in), I Unterberger, C F Ebenbichler, M Joannidis, G Walser, G Bauer, F Hoppichler, M Lechleitner

Universitätsklinik für Neurologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

78 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	42-47
Fachzeitschrift	EPILEPSY RESEARCH
Jahrgang	86
Ausgabenummer	1
DOIs	https://doi.org/10.1016/j.eplepsyres.2009.04.004
Publikationsstatus	Veröffentlicht - 2009

Zugriff auf Dokument

10.1016/j.eplepsyres.2009.04.004

Dieses zitieren

Luef, G., Rauchenzauner, M., Waldmann, M., Sturm, W., Sandhofer, A., Seppi, K., Trinka, E., Unterberger, I., Ebenbichler, C. F., Joannidis, M., Walser, G., Bauer, G., Hoppichler, F., & Lechleitner, M. (2009). Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. EPILEPSY RESEARCH , 86(1), 42-47. https://doi.org/10.1016/j.eplepsyres.2009.04.004

Luef, G ; Rauchenzauner, M ; Waldmann, M et al. / Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. in: EPILEPSY RESEARCH 2009 ; Jahrgang 86, Nr. 1. S. 42-47.

@article{81b351441d7d4ac1bb344832fa793851,

title = "Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment.",

keywords = "VALPROIC ACID, EPILEPTIC CHILDREN, METABOLIC SYNDROME, SERUM-INSULIN, OBESITY, OXIDATION, WEIGHT, WOMEN, STEATOHEPATITIS, CARBAMAZEPINE",

author = "G Luef and M Rauchenzauner and M Waldmann and W Sturm and A Sandhofer and K Seppi and Eugen Trinka and I Unterberger and Ebenbichler, \{C F\} and M Joannidis and G Walser and G Bauer and F Hoppichler and M Lechleitner",

note = "Special Institute for Preventive Cardiology and Nutrition, 5020 Salzburg, Austria",

year = "2009",

doi = "10.1016/j.eplepsyres.2009.04.004",

language = "English",

volume = "86",

pages = "42--47",

journal = "EPILEPSY RESEARCH ",

issn = "0920-1211",

number = "1",

}

Luef, G, Rauchenzauner, M, Waldmann, M, Sturm, W, Sandhofer, A, Seppi, K, Trinka, E, Unterberger, I, Ebenbichler, CF, Joannidis, M, Walser, G, Bauer, G, Hoppichler, F & Lechleitner, M 2009, 'Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment.', EPILEPSY RESEARCH , Jg. 86, Nr. 1, S. 42-47. https://doi.org/10.1016/j.eplepsyres.2009.04.004

Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. / Luef, G; Rauchenzauner, M; Waldmann, M et al.
in: EPILEPSY RESEARCH , Jahrgang 86, Nr. 1, 2009, S. 42-47.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment.

AU - Luef, G

AU - Rauchenzauner, M

AU - Waldmann, M

AU - Sturm, W

AU - Sandhofer, A

AU - Seppi, K

AU - Trinka, Eugen

AU - Unterberger, I

AU - Ebenbichler, C F

AU - Joannidis, M

AU - Walser, G

AU - Bauer, G

AU - Hoppichler, F

AU - Lechleitner, M

N1 - Special Institute for Preventive Cardiology and Nutrition, 5020 Salzburg, Austria

PY - 2009

Y1 - 2009

KW - VALPROIC ACID

KW - EPILEPTIC CHILDREN

KW - METABOLIC SYNDROME

KW - SERUM-INSULIN

KW - OBESITY

KW - OXIDATION

KW - WEIGHT

KW - WOMEN

KW - STEATOHEPATITIS

KW - CARBAMAZEPINE

U2 - 10.1016/j.eplepsyres.2009.04.004

DO - 10.1016/j.eplepsyres.2009.04.004

M3 - Original Article

C2 - 19464851

SN - 0920-1211

VL - 86

SP - 42

EP - 47

JO - EPILEPSY RESEARCH

JF - EPILEPSY RESEARCH

IS - 1

ER -

Luef G, Rauchenzauner M, Waldmann M, Sturm W, Sandhofer A, Seppi K et al. Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. EPILEPSY RESEARCH . 2009;86(1):42-47. doi: 10.1016/j.eplepsyres.2009.04.004